AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity

Abstract Background N-arachidonoylphenolamine (AM404), a paracetamol metabolite, is a potent agonist of the transient receptor potential vanilloid type 1 (TRPV1) and low-affinity ligand of the cannabinoid receptor type 1 (CB1). There is evidence that AM404 exerts its pharmacological effects in immun...

Full description

Bibliographic Details
Main Authors: Soraya Wilke Saliba, Ariel R. Marcotegui, Ellen Fortwängler, Johannes Ditrich, Juan Carlos Perazzo, Eduardo Muñoz, Antônio Carlos Pinheiro de Oliveira, Bernd L. Fiebich
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12974-017-1014-3
_version_ 1828760385973387264
author Soraya Wilke Saliba
Ariel R. Marcotegui
Ellen Fortwängler
Johannes Ditrich
Juan Carlos Perazzo
Eduardo Muñoz
Antônio Carlos Pinheiro de Oliveira
Bernd L. Fiebich
author_facet Soraya Wilke Saliba
Ariel R. Marcotegui
Ellen Fortwängler
Johannes Ditrich
Juan Carlos Perazzo
Eduardo Muñoz
Antônio Carlos Pinheiro de Oliveira
Bernd L. Fiebich
author_sort Soraya Wilke Saliba
collection DOAJ
description Abstract Background N-arachidonoylphenolamine (AM404), a paracetamol metabolite, is a potent agonist of the transient receptor potential vanilloid type 1 (TRPV1) and low-affinity ligand of the cannabinoid receptor type 1 (CB1). There is evidence that AM404 exerts its pharmacological effects in immune cells. However, the effect of AM404 on the production of inflammatory mediators of the arachidonic acid pathway in activated microglia is still not fully elucidated. Method In the present study, we investigated the effects of AM404 on the eicosanoid production induced by lipopolysaccharide (LPS) in organotypic hippocampal slices culture (OHSC) and primary microglia cultures using Western blot, immunohistochemistry, and ELISA. Results Our results show that AM404 inhibited LPS-mediated prostaglandin E2 (PGE2) production in OHSC, and LPS-stimulated PGE2 release was totally abolished in OHSC if microglial cells were removed. In primary microglia cultures, AM404 led to a significant dose-dependent decrease in the release of PGE2, independent of TRPV1 or CB1 receptors. Moreover, AM404 also inhibited the production of PGD2 and the formation of reactive oxygen species (8-iso-PGF2 alpha) with a reversible reduction of COX-1- and COX-2 activity. Also, it slightly decreased the levels of LPS-induced COX-2 protein, although no effect was observed on LPS-induced mPGES-1 protein synthesis. Conclusions This study provides new significant insights about the potential anti-inflammatory role of AM404 and new mechanisms of action of paracetamol on the modulation of prostaglandin production by activated microglia.
first_indexed 2024-12-11T01:13:05Z
format Article
id doaj.art-dece29d9a99c41a1ac18844da0b47c18
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-12-11T01:13:05Z
publishDate 2017-12-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-dece29d9a99c41a1ac18844da0b47c182022-12-22T01:25:59ZengBMCJournal of Neuroinflammation1742-20942017-12-0114111110.1186/s12974-017-1014-3AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activitySoraya Wilke Saliba0Ariel R. Marcotegui1Ellen Fortwängler2Johannes Ditrich3Juan Carlos Perazzo4Eduardo Muñoz5Antônio Carlos Pinheiro de Oliveira6Bernd L. Fiebich7Department of Psychiatry and Psychotherapy, Laboratory of Translational Psychiatry, Faculty of Medicine, Medical Center – University of FreiburgLaboratory of Hepatic Encephalopathy and Portal Hypertension, Center of Applied and Experimental Pathology, University of Buenos AiresDepartment of Psychiatry and Psychotherapy, Laboratory of Translational Psychiatry, Faculty of Medicine, Medical Center – University of FreiburgDepartment of Psychiatry and Psychotherapy, Laboratory of Translational Psychiatry, Faculty of Medicine, Medical Center – University of FreiburgLaboratory of Hepatic Encephalopathy and Portal Hypertension, Center of Applied and Experimental Pathology, University of Buenos AiresDepartamento de Biología Celular, Instituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía, Fisiología e Inmunología, Universidad de CórdobaDepartment of Pharmacology, Universidade Federal de Minas GeraisDepartment of Psychiatry and Psychotherapy, Laboratory of Translational Psychiatry, Faculty of Medicine, Medical Center – University of FreiburgAbstract Background N-arachidonoylphenolamine (AM404), a paracetamol metabolite, is a potent agonist of the transient receptor potential vanilloid type 1 (TRPV1) and low-affinity ligand of the cannabinoid receptor type 1 (CB1). There is evidence that AM404 exerts its pharmacological effects in immune cells. However, the effect of AM404 on the production of inflammatory mediators of the arachidonic acid pathway in activated microglia is still not fully elucidated. Method In the present study, we investigated the effects of AM404 on the eicosanoid production induced by lipopolysaccharide (LPS) in organotypic hippocampal slices culture (OHSC) and primary microglia cultures using Western blot, immunohistochemistry, and ELISA. Results Our results show that AM404 inhibited LPS-mediated prostaglandin E2 (PGE2) production in OHSC, and LPS-stimulated PGE2 release was totally abolished in OHSC if microglial cells were removed. In primary microglia cultures, AM404 led to a significant dose-dependent decrease in the release of PGE2, independent of TRPV1 or CB1 receptors. Moreover, AM404 also inhibited the production of PGD2 and the formation of reactive oxygen species (8-iso-PGF2 alpha) with a reversible reduction of COX-1- and COX-2 activity. Also, it slightly decreased the levels of LPS-induced COX-2 protein, although no effect was observed on LPS-induced mPGES-1 protein synthesis. Conclusions This study provides new significant insights about the potential anti-inflammatory role of AM404 and new mechanisms of action of paracetamol on the modulation of prostaglandin production by activated microglia.http://link.springer.com/article/10.1186/s12974-017-1014-3AM404AcetaminophenMicrogliaInflammationProstaglandinsCyclooxygenase
spellingShingle Soraya Wilke Saliba
Ariel R. Marcotegui
Ellen Fortwängler
Johannes Ditrich
Juan Carlos Perazzo
Eduardo Muñoz
Antônio Carlos Pinheiro de Oliveira
Bernd L. Fiebich
AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity
Journal of Neuroinflammation
AM404
Acetaminophen
Microglia
Inflammation
Prostaglandins
Cyclooxygenase
title AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity
title_full AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity
title_fullStr AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity
title_full_unstemmed AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity
title_short AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity
title_sort am404 paracetamol metabolite prevents prostaglandin synthesis in activated microglia by inhibiting cox activity
topic AM404
Acetaminophen
Microglia
Inflammation
Prostaglandins
Cyclooxygenase
url http://link.springer.com/article/10.1186/s12974-017-1014-3
work_keys_str_mv AT sorayawilkesaliba am404paracetamolmetabolitepreventsprostaglandinsynthesisinactivatedmicrogliabyinhibitingcoxactivity
AT arielrmarcotegui am404paracetamolmetabolitepreventsprostaglandinsynthesisinactivatedmicrogliabyinhibitingcoxactivity
AT ellenfortwangler am404paracetamolmetabolitepreventsprostaglandinsynthesisinactivatedmicrogliabyinhibitingcoxactivity
AT johannesditrich am404paracetamolmetabolitepreventsprostaglandinsynthesisinactivatedmicrogliabyinhibitingcoxactivity
AT juancarlosperazzo am404paracetamolmetabolitepreventsprostaglandinsynthesisinactivatedmicrogliabyinhibitingcoxactivity
AT eduardomunoz am404paracetamolmetabolitepreventsprostaglandinsynthesisinactivatedmicrogliabyinhibitingcoxactivity
AT antoniocarlospinheirodeoliveira am404paracetamolmetabolitepreventsprostaglandinsynthesisinactivatedmicrogliabyinhibitingcoxactivity
AT berndlfiebich am404paracetamolmetabolitepreventsprostaglandinsynthesisinactivatedmicrogliabyinhibitingcoxactivity